Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Customers Bancorp E Pref | 3340 | Jan 21, 2025 | 23.60 | 0.00 |
Customers Bancorp F Pref | 3341 | Jan 21, 2025 | 24.20 | 0.00 |
Customers Bancorp, Inc | 334 | Jan 21, 2025 | 47.80 | -0.42 |
Cutera, Inc. | TJ9 | Jan 21, 2025 | 0.45 | -0.33 |
CVB Financial Corporation | BCV | Jan 21, 2025 | 19.60 | -0.51 |
CVC CAPITAL PARTNERS PLC | Z1W | Jan 21, 2025 | 21.13 | -4.35 |
CVD Equipment Corporation | 0V3 | Jan 21, 2025 | 3.50 | -1.13 |
CVR Energy Inc | FL9 | Jan 21, 2025 | 20.38 | +0.54 |
CVS Group Plc | 4C9 | Jan 21, 2025 | 10.70 | +0.94 |
CVS HEALTH CDR(REG.S) | CVS0 | Jan 21, 2025 | 8.40 | +1.20 |
CVS Health Corporation | CVS | Jan 21, 2025 | 50.70 | -0.51 |
CVW CLEANTECH INC. | TMD0 | Jan 21, 2025 | 0.54 | -6.09 |
CY4GATE S.P.A. | 68H | Jan 21, 2025 | 4.38 | -0.90 |
Cyan AG | CYR | Jan 21, 2025 | 2.78 | +2.21 |
CyanConnode Holdings Plc | CUAN | Jan 21, 2025 | 0.11 | 0.00 |
Cyber Security 1 | 7CS | Jan 21, 2025 | 0.00 | -12.50 |
CyberAgent,Inc. | CL2 | Jan 21, 2025 | 6.65 | -0.75 |
CyberArk Software Ltd. - Ordinary Shares | CYB | Jan 21, 2025 | 341.80 | -1.98 |
CyberCatch Global | D0K | Jan 21, 2025 | 0.28 | +0.72 |
Cyberdyne Inc | 8C4 | Jan 21, 2025 | 1.05 | -0.76 |
CYBEROO S.P.A. | K97 | Jan 21, 2025 | 1.78 | -5.32 |
CYBERTRUST JAPAN | 5U2 | Jan 21, 2025 | 14.70 | +2.80 |
Cybin | R7E | Jan 21, 2025 | 8.50 | -0.58 |
Cyfrowy Polsat SA | CP9 | Jan 21, 2025 | 3.29 | -0.24 |
Cymbria Corp | CYOA | Jan 21, 2025 | 50.50 | +2.64 |
CYNATA THERAPEUTICS LTD Ordinary Shares(Australia) | 51S | Jan 21, 2025 | 0.12 | +1.67 |
Cytokinetics, Incorporated | KK3A | Jan 21, 2025 | 43.20 | -1.82 |
Cytomed Therapeutics | F98 | Jan 21, 2025 | 2.22 | 0.00 |
CytomX Therapeutics, Inc. | 6C1 | Jan 21, 2025 | 0.79 | -0.25 |
CYTOPHAGE TECHN. LTD. | 70G | Jan 21, 2025 | 0.16 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.